
Tema Oncology ETF – NASDAQ:CANC
Tema Oncology ETF stock price today
Tema Oncology ETF stock price monthly change
Tema Oncology ETF stock price quarterly change
Tema Oncology ETF stock price yearly change
Tema Oncology ETF key metrics
Market Cap | 48.78M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTema Oncology ETF stock price history
Tema Oncology ETF stock forecast
Tema Oncology ETF financial statements
Tema Oncology ETF other data
-
What's the price of Tema Oncology ETF stock today?
One share of Tema Oncology ETF stock can currently be purchased for approximately $26.51.
-
When is Tema Oncology ETF's next earnings date?
Unfortunately, Tema Oncology ETF's (CANC) next earnings date is currently unknown.
-
Does Tema Oncology ETF pay dividends?
No, Tema Oncology ETF does not pay dividends.
-
How much money does Tema Oncology ETF make?
Tema Oncology ETF has a market capitalization of 48.78M.
-
What is Tema Oncology ETF's stock symbol?
Tema Oncology ETF is traded on the NASDAQ under the ticker symbol "CANC".
-
What is Tema Oncology ETF's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of Tema Oncology ETF?
Shares of Tema Oncology ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Tema Oncology ETF went public?
Tema Oncology ETF is publicly traded company for more then 2 years since IPO on 14 Aug 2023.
Tema Oncology ETF company profile:
NASDAQ
0
Asset Management
Financial Services
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
,
:
ISIN: US87975E7013
: